Casserly leading Medicanja to market

Warning message

The subscription service is currently unavailable. Please try again later.

Patrick Casserly, who made his name as a businessman in the information technology market, has taken on a new challenge - ganja.

For the past seven months, Casserly has been running Medicanja Jamaica Limited as its chief executive officer, a quiet appointment that he confirmed to Wednesday Business on Monday.

His immediate focus is getting six of the company's medical marijuana products to market. That will happen by year end, said the Medicanja CEO.

"We're waiting on the necessary approvals from the Ministry of Health," he said.

"The Ministry of Health has been stellar in working hand in hand with us in bringing us to the stage where we can have prescription medication that is made in Jamaica from produce in Jamaica."

Casserly is also overseeing the plan in progress for the company to go public via the Jamaica Stock Exchange. The initial 2015 timetable has been pushed back to early 2016....

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.